A nurse is caring for a client who has been taking lisinopril for several months. The nurse should plan to check which of the following laboratory values to monitor for adverse effects of the medication?
Calcium.
Sodium.
Potassium.
Magnesium.
The Correct Answer is C
Choice A rationale
Monitoring calcium levels is not typically necessary for patients taking lisinopril, as it does not significantly affect calcium levels.
Choice B rationale
Sodium levels are not commonly affected by lisinopril, so routine monitoring is not required.
Choice C rationale
Lisinopril can cause hyperkalemia (high potassium levels), so monitoring potassium levels is crucial to prevent complications.
Choice D rationale
Magnesium levels are not significantly impacted by lisinopril, so routine monitoring is not necessary.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is B
Explanation
Choice A rationale
BNP is used to diagnose heart failure, not to monitor gentamicin’s adverse effects.
Choice B rationale
Creatinine levels should be monitored as gentamicin can cause nephrotoxicity, leading to impaired kidney function.
Choice C rationale
Amylase levels are not relevant for detecting gentamicin’s adverse effects.
Choice D rationale
ESR is used to detect inflammation, not specific to gentamicin’s adverse effects.
Correct Answer is D
Explanation
Choice A rationale
Sitagliptin is a DPP-4 inhibitor used to manage blood sugar levels in type 2 diabetes but does not specifically slow the progression of nephropathy.
Choice B rationale
Glipizide is a sulfonylurea that helps control blood sugar levels but does not have a direct effect on slowing nephropathy progression.
Choice C rationale
Metoprolol is a beta-blocker used to manage hypertension but does not specifically target nephropathy progression.
Choice D rationale
Losartan is an angiotensin II receptor blocker (ARB) that helps manage hypertension and has been shown to slow the progression of nephropathy in patients with type 2 diabetes.